Future studies using a novel approach based on hematologic indices would be useful [ 31].
These issues will be considered in future studies using the same fundamental set of methods.
This will be examined in future studies using a control group and using more quantitative approaches.
Future studies using larger and prospective cohorts will help define the role of this approach in clinical practice.
Finally, suggestions are offered regarding the design of future studies using these technologies in this population.
Future studies using tDCS to study or improve ToM, need to consider sex.
We end our commentary with a set of recommendations for future studies using PAS.
Future studies using an independent validation data set for each biodosimetry marker will confirm the capability of our protein panel to accurately predict dose.
Future studies using more clinically relevant stressors and contexts are needed to clarify whether AM404 reduces susceptibility to reinstatement in a therapeutically useful way.
However, some differences exist between human and mouse Fcγ-Rs, and future studies using humanized knock-in models would be of interest66.
However, future studies using higher treatment doses are warranted.
